Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLA? 14mm, TiZr, Loxim: medical device reports filed with FDA

3,731 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

3,731
device reports naming the brand
0% of all MAUDE reports · about 546 a year
656
reports, 12 months to August 2026
644 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

3,731 medical device reports received by FDA name the brand "BLT ?3.3mm NC, SLA? 14mm, TiZr, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

656 reports arrived in the 12 months to August 2026, close to the 644 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (76.3%), loss of osseointegration (15.8%) and difficult to insert (1.2%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

076152Sep 2021: 30Oct 2021: 34Nov 2021: 23Dec 2021: 342022Jan 2022: 66Feb 2022: 33Mar 2022: 31Apr 2022: 25May 2022: 43Jun 2022: 50Jul 2022: 45Aug 2022: 59Sep 2022: 36Oct 2022: 33Nov 2022: 56Dec 2022: 362023Jan 2023: 46Feb 2023: 48Mar 2023: 49Apr 2023: 41May 2023: 42Jun 2023: 40Jul 2023: 58Aug 2023: 45Sep 2023: 54Oct 2023: 47Nov 2023: 51Dec 2023: 372024Jan 2024: 35Feb 2024: 51Mar 2024: 35Apr 2024: 54May 2024: 56Jun 2024: 58Jul 2024: 56Aug 2024: 50Sep 2024: 50Oct 2024: 78Nov 2024: 53Dec 2024: 452025Jan 2025: 53Feb 2025: 45Mar 2025: 41Apr 2025: 21May 2025: 0Jun 2025: 152Jul 2025: 47Aug 2025: 59Sep 2025: 46Oct 2025: 81Nov 2025: 49Dec 2025: 542026Jan 2026: 45Feb 2026: 48Mar 2026: 40Apr 2026: 68May 2026: 64Jun 2026: 58Jul 2026: 51Aug 2026: 52

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03246482019: 23920192020: 34220202021: 38420212022: 51320222023: 55820232024: 62120242025: 64820252026: 4262026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,731
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report82.1%3,065
Voluntary report0%0
User facility report0%0
Distributor report17.9%666
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,84576.3%62.8%
Loss of osseointegration59015.8%22.4%
Difficult to insertthe device was hard to insert451.2%0.4%
Fracturea broken bone330.9%1.6%
Separation failure80.2%0.1%
Difficult to removethe device was hard to remove20.1%0%
Defective component10%0%
Therapeutic or diagnostic output failure10%0%
Unintended movement10%0%
Unstable10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,21432.5%
Painpain, site not specified82222%
Tissue damage3218.6%
Inflammationinflammation2697.2%
Swelling/ edema2246%
Hemorrhage/blood loss/bleeding1744.7%
Fistula1584.2%
Abscessa collection of pus1173.1%
Hyperresponsive to stimuli651.7%
Hypersensitivity/allergic reaction471.3%
Swellingswelling391%
Failure of implant270.7%
Inadequate osseointegration170.5%
Increased sensitivity50.1%
Numbnessnumbness40.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLA? 14mm, TiZr, LoximProduct code DZEAll MAUDE reports
Reports3,7313,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer82.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLA? 14mm, TiZr, Loxim reports

How many FDA reports name BLT ?3.3mm NC, SLA? 14mm, TiZr, Loxim?

3,731 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 656 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (76.3%), loss of osseointegration (15.8%), difficult to insert (1.2%), fracture (0.9%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (82.1%) and distributor reports (17.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLA? 14mm, TiZr, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.